Harrow, Inc. Preferred Stock, Value, Issued
Harrow, Inc. (HROW) had Preferred Stock, Value, Issued of $0 as of 2012-12-31, per its 10-K filed 2013-03-18.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:PreferredStockValue · last filed 2013-03-18
- 2012-12-31: Preferred Stock, Value, Issued $0.00.
- 2012-06-30: Preferred Stock, Value, Issued $0.00.
- 2012-03-31: Preferred Stock, Value, Issued $0.00.
- 2011-12-31: Preferred Stock, Value, Issued $0.00.
| Period end | Preferred Stock, Value, Issued |
|---|---|
| 2012-12-31 | $0.00 10-K · filed 2013-03-18 |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-14 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-10 |
| 2011-12-31 | $0.00 10-K · filed 2013-03-18 |
| 2011-09-30 | $0.00 10-Q · filed 2012-02-23 |
| 2011-06-30 | $0.00 10-Q · filed 2012-02-23 |
| 2010-12-31 | $0.00 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |